Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - ThermoGenesis Holdings, Inc. | ex99.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 12, 2013
THERMOGENESIS CORP.
(Exact name of registrant as specified in its charter)
|
Delaware
|
333-82900
|
94-3018487
|
||
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2711 Citrus Road
Rancho Cordova, California 95742
(Address and telephone number of principal executive offices) (Zip Code)
(916) 858-5100
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
- 1 -
Item 2.02 Results of Operations and Financial Condition
Item 2. On February 12, 2013, ThermoGenesis Corp. issued a press release announcing its results of operations and financial condition for the quarter ended December 31, 2012. The full text of the press release is set forth in Exhibit 99.1 attached to this report.
Item 9.01 Financial Statements and Exhibits
99.1 Press release dated February 12, 2013, titled “ThermoGenesis Reports Second Quarter Fiscal 2013 Results; Net Loss Reduced by 56 Percent Year-Over-Year; Positive Clinical Study Results Published”
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
THERMOGENESIS CORP.,
|
|||
|
a Delaware Corporation
|
|||
|
/s/ Matthew T. Plavan
|
|||
|
Matthew T. Plavan,
|
|||
|
Chief Executive Officer and Chief Financial Officer
|
|||
- 3 -
Exhibit Index
|
Exhibit No.
|
Description
|
|||
|
99.1
|
Press release dated February 12, 2013, titled “ThermoGenesis Reports Second Quarter Fiscal 2013 Results; Net Loss Reduced by 56 Percent Year-Over-Year; Positive Clinical Study Results Published”
|
|||
- 4 -